EKF Diagnostics Holdings plc
EKF.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £25 | £25 | £25 | £26 |
| % Growth | 1% | -0.9% | -2% | – |
| Cost of Goods Sold | £13 | £13 | £13 | £13 |
| Gross Profit | £13 | £12 | £12 | £12 |
| % Margin | 50.2% | 49.4% | 47.8% | 48.2% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £9 | £9 | £9 | £9 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £9 | £9 | £9 | £9 |
| Operating Income | £3 | £3 | £3 | £4 |
| % Margin | 13.8% | 13.7% | 11.5% | 14.3% |
| Other Income/Exp. Net | £0 | -£0 | £0 | -£2 |
| Pre-Tax Income | £4 | £3 | £3 | £2 |
| Tax Expense | £2 | -£1 | £1 | -£1 |
| Net Income | £2 | £4 | £2 | £3 |
| % Margin | 7.7% | 16.7% | 8.2% | 10.5% |
| EPS | 0.004 | 0.009 | 0.005 | 0.006 |
| % Growth | -53.3% | 100% | -23.3% | – |
| EPS Diluted | 0.004 | 0.009 | 0.005 | 0.006 |
| Weighted Avg Shares Out | 452 | 454 | 454 | 454 |
| Weighted Avg Shares Out Dil | 452 | 454 | 454 | 454 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £2 | £2 | £2 | £2 |
| EBITDA | £6 | £6 | £6 | £4 |
| % Margin | 23.2% | 22.4% | 22% | 17.1% |